AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
An analysis of Orvellaity, a quick-acting antidepressant, tested in treatment-resistant depression but failing to outperform placebo. Dr. Aiken's article explores the complexities of researching new medications for true treatment-resistant depression.